Farbod Khosravi

Dr. Farbod Khosravi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2025 in Regenerative Therapy
Verified
Journal Article
Open access
FRFatemeh Rafati
Fatemeh Rafati
ZGZeynab Ghorbani
Zeynab Ghorbani
TMTahereh Manoochehrabadi
Tahereh Manoochehrabadi
FKFarbod Khosravi
Farbod Khosravi
JMJila Majidi
Jila Majidi
HNHajar Nasiri
Hajar Nasiri
Mesenchymal stem cells (MSCs) and their exosome (MSCs-Exos) have been shown to be major therapeutic candidates in regenerative medicine due to their inherent capacity for modulating immune response, promoting angiogenesis, and repairing tissues. However, clinical application of MSCs and MSCs-Exos is hindered by various intrinsic barriers, such as poor survival of transplanted MSCs, quick systemic clearance of exosomes, uncontrolled release of therapeutic payloads, and loss of function in severe pathological situations, such as chronic wounds and fibrotic tissues. To overcome these limitations, recent advances have focused on the design of modern delivery systems to enhance the stability, bioavailability, and functionality of MSCs and MSCs-Exos. These platforms include responsive hydrogels, engineered nanoparticles, and multi responsive intelligent dressings that mirror protective microenvironments in general and provide controlled, long-term distribution of bioactive elements. This current review focuses on such innovative approaches that enhance regeneration results in strong preclinical models, maximize therapeutic delivery, and boost MSCs and exosome survival. Despite remarkable advancements, major obstacles still exist, such as guaranteeing biosafety, achieving scale production, and obtaining regulatory approvals. The combination of MSCs and MSCs-Exos therapies with intelligent, responsive biomaterials capable of providing antimicrobial function and active monitoring has the potential to revolutionize tissue regeneration and wound healing and make MSCs and MSCs-Exos invaluable resources in precision regenerative medicine of the future.

1 January 2020 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
FKFarbod Khosravi
Farbod Khosravi
PZPardis Ziaeefar
Pardis Ziaeefar
Background: Although children with inflammatory bowel disease (IBD), disease control is possible through medical procedures, but surgical intervention is indicated in some cases. Aim: To evaluated long-term surgical outcomes in children with IBD. Methods: This retrospective cohort study was done on 21 children suffering IBD with surgical indication admitted to a referral children hospital in Tehran in 2019. The baseline information was collected by reviewing the recorded files and children were followed-up to assess surgical outcome. Results: The rate of early complications after surgery was 47.6%; they included intestinal perforation in 4.8%, peritonitis in 4.8%, wound infection in 23.8%, pelvic abscesses in 14.3%, deep vein thrombosis in 4.8%, intestinal obstruction in 9.5%, pancreatitis in 9.5% and anal fissure in 4.8%. The mean duration of follow-up for patients was 6.79±4.24 years. The rate of delayed complications during follow up was 28.6%. Accordingly, long-term free-complication survival rate during 5-10 years after surgery was 92.3% and 56.4%, respectively. Among the early features, lack of prior drug treatment and bleeding as indication for surgery, were two predictors of long-term surgical complications. Conclusion: Standard surgery in the treatment of IBD in children with surgical indication is associated with favorable outcome, although short- and long-term surgical complications are also predictable.

25 November 2025 in Scientific Reports
Verified
Journal Article
Open access
HNHamide Nasiri
Hamide Nasiri
FKFarbod Khosravi
Farbod Khosravi
PSParsa Saberian
Parsa Saberian
MKMelika Kavian
Melika Kavian
MMMehrdad Mozafar
Mehrdad Mozafar
MBMaryam Bemanalizadeh
Maryam Bemanalizadeh
White matter hyperintensity (WMH), indicative of cerebral small vessel disease, has emerged as a potential biomarker for cognitive decline in Alzheimer's disease (AD). However, their predictive role across specific cognitive domains within the AD spectrum remains unclear. This study investigates the relationship between WMH volume and cognitive performance in memory, executive function, and language across the AD continuum. A cross-sectional analysis was conducted using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), comprising 557 participants categorized into cognitively normal (CN; n = 158), mild cognitive impairment (MCI; n = 334), and Alzheimer's dementia (AD; n = 65) groups. Cognitive function was assessed using composite scores for memory (ADNI-MEM), executive function (ADNI-EF), and language (ADNI-LAN). WMH volume was quantified through validated Bayesian segmentation of MRI data. Associations between cognitive scores and WMH volume, adjusted for age, gender, APOE ε4 status, and vascular risk factors, were evaluated via multiple linear regression analyses. WMH volume showed numerically progressive increases from CN to MCI and AD groups; however, between-group differences did not reach statistical significance. Within the MCI group, significant negative associations emerged between WMH volume and memory (β=-0.13, adjusted p = 0.045) and language scores (β=-0.12, adjusted p = 0.045). Conversely, these relationships were absent in both the CN and AD groups. WMH volume relates specifically to declines in memory and language abilities, particularly in individuals with MCI. These results support using WMH measurements as early markers to identify cognitive decline in AD, potentially helping to guide earlier diagnosis and treatment decisions.

25 November 2025 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
PDF file
AAAida Azhdarimoghaddam
Aida Azhdarimoghaddam
ABAlireza Mohammad Bigloo
Alireza Mohammad Bigloo
MMMohammad Saeed Soleimani Meigoli
Mohammad Saeed Soleimani Meigoli
MAMuhammed Abdelbaset
Muhammed Abdelbaset
MNMaryam Narimani
Maryam Narimani
MAMohamed Abouzeid
Mohamed Abouzeid
Gastric cancer (GC) remains a significant global health burden, with high mortality due to delayed diagnosis. Advances in microbiome profiling and artifici

20 February 2026 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
ASAbbas Sarvari Soltani
Abbas Sarvari Soltani
PSPardis Soroush
Pardis Soroush
SMSamira Masoumi
Samira Masoumi
MNMatin Noroozi
Matin Noroozi
MVMahdiyeh Nozad Varjovi
Mahdiyeh Nozad Varjovi
MAMohadeseh Ahmadlou
Mohadeseh Ahmadlou
Dual targeting with onabotulinumtoxinA and anti-CGRP monoclonal antibodies has emerged as a potential option for patients with chronic migraine who respond

24 December 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
RMRaha Motamedi
Raha Motamedi
FMFatemeh Hayeri Mehrizi
Fatemeh Hayeri Mehrizi
MAMohaddeseh Zeinali Ali Abadi
Mohaddeseh Zeinali Ali Abadi
MMMohamadreza Mohagheghi
Mohamadreza Mohagheghi
FFFatemeh Nourollahi Fomeshi
Fatemeh Nourollahi Fomeshi
SSSareh Saien
Sareh Saien
Psychiatric disorders such as schizophrenia, bipolar disorder, major depression, and dementia are increasingly associated with specific ocular and retinal